Project Grant R01HL171731
Award Date
9/15/24
Completion Date
6/30/29
Dollars Obligated
$816K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
This Project Grant award of $597,904 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate the impact of the infant microbiome and its interactions with host genetics on the risk of childhood asthma. The primary objectives are to: (1) detect host genome-wide associations with the infant microbiome; (2) identify genotype-microbiome interaction effects on childhood asthma; and...
This $915,924 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to investigate how early-life disruptions to lung microbiome composition, such as through antibiotic use, can impair the development and function of lung immune cells and epithelial cells. The research aims to elucidate the critical window during which the lung microbiome programs long-term lung homeostasis, and explore...
This Project Grant award of $508,500 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate the relationships between breastfeeding, early-life microbiome development, and childhood respiratory health outcomes. The study will leverage two established birth cohorts to investigate microbial colonization patterns across nasal/airway and gut niches, identifying genetic...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $143,609 to Vanderbilt University Medical Center (VUMC) to elucidate the relationship between placental gene expression, newborn metabolites, and the development of childhood asthma. The primary objectives are to: 1) Determine associations between predicted gene expression in the human placenta and early life...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research aimed at understanding how neonatal infections with the human metapneumovirus (HMPV) can lead to the development of asthma later in life. The $391,779 award will fund a 5-year research project to evaluate the role of neonatal CD4+ T cell responses, regulatory T cells, and altered T cell metabolism in...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $197,748 to conduct research on healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) in neonatal intensive care units (NICUs). The key objectives of this research project are to: 1) Identify nosocomial transmission of viral and bacterial pathogens in the NICU through metagenomic...
This federal Project Grant award of $704,105, funded by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program, supports research to investigate the complex associations between multiple long-term environmental exposures, such as air pollution, temperature, and greenspace, and the incidence of asthma. The study, conducted by Brigham & Women's Hospital Inc. and its parent organization Partners Healthcare System Incorporated, will...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is providing $781,129 to The Regents of the University of California, San Francisco (UCSF) to conduct a prospective, multicenter cohort study of 400 critically ill children with acute respiratory failure. The key objectives are to: 1) independently validate the performance of UCSF's existing integrated host/microbe...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $746,134 to Vanderbilt University Medical Center (VUMC) to investigate the direct immunologic mechanisms by which GLP-1 receptor agonists reduce inflammation in both lean and obese patients with asthma. The research aims to: 1) Evaluate the anti-inflammatory role of GLP-1 signaling in platelet-derived T2 and non-T2...
This federal Project Grant award, valued at $249,000.00, was provided by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant supports the development of computational methodologies to profile the blood microbiome and its relationship to the gut-lung axis in asthma pathogenesis. Key objectives include creating a strain-resolved computational pipeline for reduced metagenomic sequencing of blood samples and developing a...